The Nephron journals/Nephron journals · 2002 · 33 citations · 18 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyRenal PathophysiologyRenal PharmacotherapyHypertension ManagementHypertension PharmacotherapyHypertensive NephropathyHypertensive NephrosclerosisRenal DiseaseRenal PharmacologyAngiotensin Ii Receptor BlockersAntihypertensive PharmacologyBlood PressureRenin-angiotensin System InhibitorsRenin-angiotensin-aldosterone System BlockadeRenin-angiotensin-aldosterone System InhibitionRenin-angiotensin-aldosterone System InhibitorsSalt-sensitive Hypertension
Recently, we have shown that treatment of stroke-prone spontaneously hypertensive rats with angiotensin inhibitors for a limited time-window before puberty results in an attenuation of hypertensive nephrosclerosis in later life. The aim of this study was to examine the applicability of this therapeutic paradigm to a low-renin model. Dahl salt-sensitive (Dahl-S) rats were fed a high-salt diet from age 6 weeks. Some rats were treated with the angiotensin receptor blocker (ARB) candesartan cilexetil (2 mg/kg/d) from weaning to puberty (age 3-10 weeks), whereas other rats were treated continuously until overt renal damage was seen (age 3-16 weeks). Dahl-S rats on a high salt diet had increased blood pressure (207 +/- 3 vs. 125 +/- 2 mm Hg), proteinuria, and glomerular/vascular histological changes. The prepubertal treatment with ARB resulted in a continued suppression of blood pressure (153 +/- 2 mm Hg) at 16 weeks. Both proteinuria and renal histological changes were significantly (p < 0.05) attenuated, but not completely prevented by the treatment. No significant differences in plasma renin activity, renin mRNA, or AT1/AT2 mRNA were seen between groups. These results suggest that prepubertal treatment affords sustained renoprotection, even in an animal model with a suppressed renin-angiotensin system, and support the notion that appropriate prepubertal intervention may lead to a partial attenuation in the susceptibility to inherited renal diseases.
18